000			02274nam a2200469 i 4500
001			on1175662157
003			OCoLC
005			20200902124616.0
006			m o d f
007			cr |||||||||||
008			200717s2020 dcu o f000 0 eng c
024	8		_a30-644 _q(GPO jacket number)
040			_aGPO _beng _erda _epn _cGPO _dMvI
042			_apcc
043			_an-us---
050		4	_aKF26 _b.L27 2018t
074			_a1043-C (online)
086	0		_aY 4.L 11/4:S.HRG.115-827
099			_aY 4.L 11/4:S.HRG.115-827
110	1		_aUnited States. _bCongress. _bSenate. _bCommittee on Health, Education, Labor, and Pensions, _eauthor.
245	1	0	_aEffective administration of the 340B Drug Pricing Program : _bhearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining effective administration of the 340B Drug Pricing Program, June 19, 2018.
264		1	_aWashington : _bU.S. Government Publishing Office, _c2020.
300			_a1 online resource (iii, 35 pages).
336			_btxt
337			_bc _2rdamedia
338			_bcr _2rdacarrier
490	1		_aS. hrg. ; _v115-827
500			_aAccess ID (govinfo): CHRG-115shrg30644.
500			_aGPO Cataloging Record Distribution Program (CRDP).
511	0		_aHearing witnesses: Pedley, Captain, Krista M., PHARM.D., M.S., Director, Office of Pharmacy Affairs, Healthcare Systems Bureau, Health Resources and Services Administration, U.S. Department of Health and Human Services, Rockville, MD.
518			_aDate of hearing: 2018-06-19.
588			_aDescription based on online resource; title from PDF title page (govinfo, viewed July 17, 2020).
610	1	0	_aUnited States. _bHealth Resources and Services Administration _xRules and practice.
610	2	0	_a340B Drug Pricing Program (U.S.) _xAuditing.
650		0	_aPrescription pricing _xGovernment policy _zUnited States.
650		0	_aPoor _xPharmaceutical assistance _zUnited States.
655		7	_aLegislative hearings. _2lcgft
810	1		_aUnited States. _bCongress. _bSenate. _tS. hrg. ; _v115-827.
856	4	0	_uhttps://purl.fdlp.gov/GPO/gpo141549
922			_aGOVINFOHRG
922			_aBIBCONEW _b20200717
999			_c294908 _d294908